Navigation Links
51st Food and Drug Law Institute Annual Conference Focuses on Relationship Between Scientific Advances and FDA Law & Regulation
Date:1/9/2008

U.S. Supreme Court Justice Antonin Scalia, FDA Commissioner Andrew C. von Eschenbach Among Featured Speakers at March 26-27, 2008, FDLI/FDA Meeting in Washington, D.C.

WASHINGTON, Jan. 9 /PRNewswire-USNewswire/ -- The Food and Drug Law Institute's 51st Annual Conference, co-sponsored with the Food and Drug Administration, will focus on the interrelationship between scientific and technological advances and food & drug law & regulation.

FDLI/FDA's March 26-27, 2008 meeting at the L'Enfant Plaza Hotel in Washington, D.C., will include a luncheon speech by U.S. Supreme Court Justice Antonin Scalia and a State of the FDA address by Commissioner Andrew C. von Eschenbach, M.D. Rep. John D. Dingell (D-Mich.) is also an invited featured speaker.

As noted in the recent FDA Science and Mission at Risk Report (http://backweb.fdli.org/pdf/FDAScience.pdf), scientific advances often pose significant policy issues and challenges for legal and regulatory systems. While government agencies are authorized to develop and implement policies that stimulate scientific advances for the benefit of public health, they are also mandated to ensure safety, effectiveness and affordability. The FDLI annual meeting, Scientific Revolution and Legal Evolution: Keeping Pace with Science & Policy Issues in Food and Drug Law, focuses on these dynamic tensions while informing attendees about the impact of recent wide-sweeping food and drug legislation.

Other featured speakers include:

J. Scott Ballenger, Partner, Latham & Watkins;

Brian J. Donato, Partner, Hyman, Phelps & McNamara;

Lillian J. Gill, Director, Office of Compliance, Centers for Devices and Radiological Health, FDA;

Jesse L. Goodman, M.D., Director, Center for Biologics Evaluation and Research, FDA;

Peter Barton Hutt, Partner, Covington & Burling;

Gerald F. Masoudi, Associate General Counsel, Food & Drug Division, Department of Health & Human Services;

Daniel Meron, General Counsel, Department of Health and Human Services;

Thomas Miller, Member, Managing Board, Siemens Medical Solutions;

Paula A. Monopoli, Professor, University of Maryland School of Law & Founding Director, Women, Leadership & Equality Program;

Lydia Parnes, Director, Office of Consumer Protection, Federal Trade Commission;

David Schmidt, President & CEO, International Food Information Council;

Barry M. Straube, M.D., Chief Medical Officer, Center for Medicare & Medicaid Services;

Daniel E. Troy, Partner, Sidley Austin;

Janet Woodcock, M.D., Deputy Commissioner and Chief Medical Officer, FDA; and

Julie Zawisza, Assistant Commissioner for Public Affairs, FDA.

For a complete list of speakers and agenda, visit http://www.fdli.org.

The Early Bird Rates, effective through Feb. 15, are:

Both One Day

Days Only

$945 $795 FDLI Members

$1,270 $1,020 Non-members

$395 $345 Government (Non-FDA, including FDAAA members who

are not currently employed)

$670 $470 Academics, 501(c)(3) Non-Profits

$399 $199 Full Time Students (Special discount: $350 for a

group of 5 or more who register for both days)

To register for the conference, visit http://www.fdli.org or call (800)956-6923 or (202) 371-1420.

Founded in 1949, FDLI publishes the award-winning, peer-reviewed Food and Drug Law Journal; the bimonthly magazine Update; FDA Directory; and dozens of books and publications for attorneys, regulatory affairs practitioners, scientists, health care professionals, government employees and marketers in the food and drug field. For more information, visit http://www.fdli.org


'/>"/>
SOURCE Food and Drug Law Institute
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. DaVita and Phoenix-Based Southwest Kidney Institute Form Broad Partnership
2. MCG receives second-time designation from National Cancer Institute
3. Food and Drug Law Institute Sponsors Major Enforcement Conference
4. Food and Drug Law Institute, Project on Emerging Nanotechnologies Co-Sponsor Major Conference on Nanotechnology Law, Regulation and Policy
5. National Institute on Drug Abuse Director Nora Volkow Speaks about the Dangers of Narcotics on Azteca Americas Political Forum Issues: Caras y Voces
6. OHSU Cancer Institute researcher discovers what fuels certain cancer mutation
7. OHSU Cancer Institute researcher develops test for targeted therapy in acute myeloid leukemia
8. OHSU Cancer Institute research discovery opens new window to understanding chronic myeloid leukemia
9. Stem Cell Institute Correct in Rejecting Applications Over Conflicts of Interest; Institutions, Board Members Involved Must Be Identified, Consumer Advocates Say
10. The Roskamp Institute Receives Award of Appreciation for Its Continued Innovative and Technological Advances
11. EEG Institute to Provide Free Post-Traumatic Stress Treatment for Iraq and Afghanistan Veterans
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... Dallas, Texas (PRWEB) , ... June 24, 2016 ... ... 12th International Conference and Scientific Sessions in Dallas that it will receive two ... Announcement of the grants came as PHA marked its 25th anniversary by recognizing ...
(Date:6/24/2016)... ... June 24, 2016 , ... Dr. Amanda Cheng, an ... Dr. Cheng has extensive experience with all areas of orthodontics, including robotic Suresmile ... orthodontics. , Micro-osteoperforation is a revolutionary adjunct to orthodontic treatment. It can ...
(Date:6/24/2016)... ... ... BioMedics, Inc, makers of Topricin and MyPainAway Pain Relief Products, join The ‘Business for a ... an hour by 2020 and then adjusting it yearly to increase at the same rate ... assure the wage floor does not erode again, and make future increases more predictable. , ...
(Date:6/24/2016)... ... 2016 , ... EB Medicine presented its first-ever “Issue of ... in Ponte Vedra Beach, FL. The awards honor the outstanding work of leading ... and Pediatric Emergency Medicine Practice. , “With this award, we recognize the efforts ...
(Date:6/24/2016)... , ... June 24, 2016 , ... ... The Grove Investment Group (TGIG), has initiated cultivation and processing operations at its ... Vegas and Pahrump, Nevada. , Puradigm is the manufacturer of a complete system ...
Breaking Medicine News(10 mins):
(Date:6/26/2016)... of Australia,s successful biotechnology scientists, Dr ... company, Noxopharm Limited [ABN 50 608 966 123] ("Noxopharm"). Noxopharm is ... the ASX. Noxopharm is a clinic-ready company with its ... clinical study later this year. ... facing cancer patients - the ability of cancers to become resistant ...
(Date:6/26/2016)... , June 27, 2016 Jazz Pharmaceuticals ... waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of ... acquisition of Celator Pharmaceuticals, Inc. ("Celator"; Nasdaq: ... p.m. (Eastern Daylight Time). As previously announced ... into a definitive merger agreement under which Jazz Pharmaceuticals ...
(Date:6/26/2016)... Ontario , June 27, 2016  VMS Rehab ... Company,s Board will take whatever measures required to build ... Company,s stock which is currently listed on the OTC ... Wexler, Company Chairman and CEO, "We are seeing an ... difficult to understand, not only by the Company, but ...
Breaking Medicine Technology: